• Pharma
  • July 11, 2019
  • 4 views
Glenmark Pharma anti-diabetes durg on signing licensing agreement with Torrent Pharma

Mumbai :  Glenmark Pharmaceuticals is currently trading at Rs. 453.20, up by 7.70 points or 1.73% from its previous closing of Rs. 445.50 on the BSE. The scrip opened at…

Price War In Anti Diabetic Medicine Segment

A price war is brewing in India’s growing diabetes drug market, drawing comparisons with the recent tariff battles in the telecom sector. Glenmark Pharmaceuticals NSE -1.45 % has launched a patented…